Helen Susan Kim, EVP, Business Development at Kite Pharma, Inc. (KITE), sold 12,502 shares at $120.09 ($1.5M) on 2017-08-10, disclosed to the SEC on 2017-08-14.
Open-market sale of $1.5M KITE by EVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.09 | 6,251 | $751K | 50.0% |
| 2 | $120.09 | 6,251 | $751K | 50.0% |
| Total | $120.09 avg | 12,502 | $1.5M | 100% |
| Filing → |
| AMTI | SELL | 2021-08-25 | $585K | — | Filing → |
| AMTI | SELL | 2021-07-06 | $17.3M | — | Filing → |
| KITE | SELL | 2017-09-27 | $1.1M | — | Filing → |